The reported prevalence of Chronic Obstructive Pulmonary Disease(COPD) in people living with HIV(PLWH) varies widely(7-60%) depending on the study population and methods used, underscoring the uncertainty of the estimates. Our objective was to estimate the prevalence of COPD in unselected PLWH and identify characteristics that increase the risk of non-reversible airflow obstruction using spirometry-the gold standard-in order to guide screening strategies for COPD.
This study was conducted at the Chronic Viral Illness Service at the McGill University Health Centre in Montreal, Canada(population≈2000 PLWH). All persons ≥18 years of age with HIV were invited to participate, regardless of smoking status or history of known COPD/asthma. Individuals with acute respiratory infection were excluded. Individuals underwent standard spirometric testing both pre and post salbutamol bronchodilator and completed the MRC dyspnea scale, which rates the severity of dyspnea on a scale of 1-5. The presence of COPD(FEV1/FEV<0.7 post-bronchodilator) was determined and multivariate logistic regression was used to evaluate risk factors associated with COPD, reported as adjusted odds ratios(aOR).
There were 369 participants of whom 39(11%) had COPD on spirometry. Median age (Q1;Q3) was 51(44;58), and 30% were female. Most were Caucasian(57%), followed by Black African (22%). Participants had a median duration of HIV of 15 years(9; 22) and 94% were on antiretrovirals for a median duration of 10(6;16) years with 92% virally suppressed. Median CD4 count was 594(440;786) and nadir CD4 count was 234 (128;376) cells/uL. Median MRC dyspnea score was 1(1;2), implying a low burden of dyspnea. Results of spirometry testing are depicted in Table 1 and demonstrate a high proportion of patients with reversible airflow obstruction. The following risk factors for COPD were assessed: smoking history(aOR: 2.96, 95% CI: [1.36; 7.03]), age(2.02 [1.41; 2.97]), female sex(0.72 [0.23; 1.9]), and higher nadir CD4 count(0.85 [0.69; 1.03] per 100 cells).
Both smoking status and older age independently predicted the presence of non-reversible airflow obstruction in PLWH. Low nadir CD4 appeared to be associated with the presence of COPD. These findings suggest that PLWH who are ≥50 years, smokers and those with nadir CD4 counts ≤200 cells/µL should undergo spirometry screening for COPD. The high rate of reversible airflow obstruction is a novel finding and merits further exploration.